# Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

> **NCT03322345** · — · ENROLLING_BY_INVITATION · sponsor: **University of Michigan** · enrollment: 24 (estimated)

## Conditions studied

- Dopamine
- Protein-Losing Enteropathies
- Lymphatic System
- Lymph
- Catecholamine
- Single-ventricle
- Congenital Heart Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03322345
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2019-04-09
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03322345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03322345, "Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03322345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*